-
Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere.
Roche Products Ltd., Welwyn Garden City, Hertfordshire, United Kingdom.
PMID: 1956054 [PubMed - indexed for MEDLINE]
-
Cited by 12 PubMed Central articles
-
ReviewResilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
Lefebvre E, Schiffer CA.
AIDS Rev. 2008 Jul-Sep; 10(3):131-42.
[AIDS Rev. 2008]
-
Evaluating the potency of HIV-1 protease drugs to combat resistance.
Hou T, McLaughlin WA, Wang W.
Proteins. 2008 May 15; 71(3):1163-74.
[Proteins. 2008]
-
Role of invariant Thr80 in human immunodeficiency virus type 1 protease structure, function, and viral infectivity.
Foulkes JE, Prabu-Jeyabalan M, Cooper D, Henderson GJ, Harris J, Swanstrom R, Schiffer CA.
J Virol. 2006 Jul; 80(14):6906-16.
[J Virol. 2006]
- » See all...
Structures reported by this article